Inovet
Xavier Chatenet has extensive experience in the veterinary field, currently serving in vet services and technical support for the pharmaceutical industry at Inovet since January 2020. Prior to this role, Xavier Chatenet was the owner of Labovet conseil from January 2003 to December 2019. Xavier Chatenet's educational background includes a DEA in Oceanography, Marine Biology, and Biological Oceanography from Université d'Aix Marseille (1987-1988) and a veterinary degree from École nationale vétérinaire de Nantes (1983-1987).
This person is not in the org chart
This person is not in any offices
Inovet
Inovet is a veterinary pharmaceutical company active worldwide and dedicated to research, production and marketing of veterinary pharmaceuticals and animal health products. Inovet has divisions in Belgium (V.M.D. nv/sa), France (Laboratoires Biové S.A.S.), Hungary (V.M.D. Állatgyógyászati Kft), and Vietnam (Inovet Indochine). Inovet is part of the Orion Group. Inovet offers over 220 different pharmaceutical products and over 1,200 international marketing authorizations, under the umbrella of two leading veterinary brands: VMD® Livestock pharma and Biové® Laboratoires. Inovet provides an extensive range of registered antibiotics, chemotherapeutics, vitamins, local anesthetics, anti-inflammatory, analgesic, antipyretic agents, hormonal, and anti-parasitic products in the form of injectable preparations, water-soluble powders, oral solutions, and premixes. The production facility of Inovet (Laboratoires Biové S.A.S.) is located in Arques, France. The facility has four production units for pharmaceutical products: injectable solutions and suspensions, oral powders, oral liquids, and anti-parasitic products (powders, solutions, and collars). A fifth unit is dedicated to the production of complementary feeds. In addition to the production of the group’s own brands, Inovet offers extensive toll manufacturing services.